Skip to main content
Premium Trial:

Request an Annual Quote

Case Western Licenses HIV Dx Technology to UH Case Medical Center

NEW YORK (GenomeWeb News) – Case Western Reserve University said today that it has licensed exclusive worldwide rights to University Hospitals Case Medical Center to a series of HIV diagnostic tests.

The phenotypic and genotypic HIV tests were invented by Eric Arts, a professor of medicine in the division of infectious diseases at Case Western Reserve School of Medicine, and Miguel Quiñones-Mateu, an assistant professor in the department of pathology. The tests determine drug resistance and co-receptor tropism in HIV, said Case Western.

The HIV phenotypic assays are called Viralarts HIV and Veritrop. The HIV genotyping and co-receptor tropism test is called Deepgen HIV and is based on next-generation sequencing technology, according to Quiñones-Mateu.

He said that in collaboration with Christine Schmotzer, medical director of the University Hospitals Translational Laboratory and assistant professor of pathology in the school of medicine, "we are ready to introduce our unique products and services to HIV physicians, pharmaceutical drug companies developing the next generation of effective drugs, and national laboratory service organizations that interact with both groups."

The medical center created UHTL in 2011 with the aim of developing new molecular diagnostic technologies that are initially conceived in the academic and clinical laboratories at the medical center and the university.